Clinical Trial Update: Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update reports survival outcomes and tumor molecular profiling after bicalutamide neoadjuvant therapy in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

Sponsor: University of L'Aquila | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED